HEALTHCARE RESOURCE UTILIZATION IN PATIENTS TREATED WITH EMPAGLIFLOZIN IN EAST ASIA: RESULTS FROM EMPRISE STUDY

被引：0
|
作者：
Sheu, Wayne [1 ]
Seino, Yutaka [1 ]
Tan, Elise [1 ]
Yabe, Daisuke [1 ]
Ha, Kyoung Hwa [1 ]
Chung, Wook-Jin [1 ]
Taneda, Yusuke [1 ]
Lei, Wei-Yu [1 ]
Ustyugova, Anastasia [1 ]
Klement, Riho [1 ]
Deruaz-Luyet, Anouk [1 ]
Kyaw, Moe [1 ]
Kim, Dae Jung [1 ]
机构：
[1] Boehringer Ingelheim Pharmaceut Inc, EMPRISE East Asia Study Grp, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1470 / 1470
页数：1
相关论文
共 50 条
  • [21] Effectiveness and Safety of Empagliflozin in Routine Care Patients: Interim Results from the EMPagliflozin compaRative effectiveness and SafEty (EMPRISE) Study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Bessette, Lily G.
    Franklin, Jessica
    Najafzadeh, Mehdi
    Wexler, Deborah J.
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly
    Schneeweiss, Sebastian
    DIABETES, 2020, 69
  • [22] Empagliflozin on the Risk of Retinopathy in Patients with Type 2 Diabetes-Results from the EMPRISE Study
    Tesfaye, Helen
    Htoo, Phyo T.
    Paik, Julie M.
    Zakoul, Heidi
    Schmedt, Niklas
    Deruaz-Luyet, Anouk
    Koeneman, Lisette
    Wexler, Deborah J.
    Patorno, Elisabetta
    DIABETES, 2023, 72
  • [23] Comparative Safety of Empagliflozin in Routine Care Patients: Interim Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Patorno, Elisabetta
    Tesfaye, Helen
    Wexler, Deborah J.
    Glynn, Robert
    Najafzadeh, Mehdi
    Bessette, Lily G.
    Zakoul, Heidi
    Koeneman, Lisette
    Deruaz-Luyet, Anouk
    Schneeweiss, Sebastian
    DIABETES, 2021, 70
  • [24] Reduced healthcare utilization in routine care initiators of empagliflozin with and without heart failure: interim analysis from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Pawar, A.
    Patorno, E.
    Deruaz-Luyet, A.
    Brodovicz, K.
    Ustyugova, A.
    Gautam, N.
    Ortiz, A. Santiago
    Schneeweiss, S.
    Najafzadeh, M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3063 - 3063
  • [25] Effectiveness and Safety of Empagliflozin in Routine Care: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Htoo, Phyo T.
    Tesfaye, Helen
    Paik, Julie M.
    Wexler, Deborah J.
    Najafzadeh, Mehdi
    Glynn, Robert
    Deruaz-Luyet, Anouk
    Farsani, Soulmaz F. Fazeli
    Koeneman, Lisette
    Schneeweiss, Sebastian
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [26] Effectiveness and safety of empagliflozin in routine care: Results from the empagliflozin comparative effectiveness and safety (emprise) study
    Htoo, Phyo
    Tesfaye, Helen
    Paik, Julie
    Wexler, Deborah
    Najafzadeh, Mehdi
    Glynn, Robert
    Deruaz-Luyet, Anouk
    Farsani, Soulmaz
    Koeneman, Lisette
    Schneeweiss, Sebastian
    Patorno, Elisabetta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 40 - 41
  • [27] Healthcare Resource Utilization Among Empagliflozin Initiators With and Without Cardiovascular Disease versus DPP4i in a Commercially-Insured Routine Care Population: An Analysis From the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Najafzadeh, Mehdi
    Pawar, Ajinkya
    Schneeweiss, Sebastian
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly
    Ustyugova, Anastasia
    Gautam, Nileesa
    Patorno, Elisabetta
    CIRCULATION, 2019, 140
  • [28] Empagliflozin selected cardiovascular and safety outcomes in routine care: first results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Patorno, E.
    Pawar, A.
    Franklin, J. M.
    Najafzadeh, M.
    Deruaz-Luyet, A.
    Brodovicz, K. G.
    Sambevski, S.
    Bessette, L.
    Kulldorff, M.
    Schneeweiss, S.
    DIABETOLOGIA, 2019, 62 : S329 - S330
  • [29] COMPARATIVE HEALTHCARE COSTS AND MEDICATION BURDEN IN REAL-WORLD PATIENTS AUGMENTING METFORMIN MONOTHERAPY WITH EMPAGLIFLOZIN FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY
    Pawar, A.
    Patorno, E.
    Deruaz-Luyet, A.
    Brodovicz, K. G.
    Ustyugova, A.
    Bessette, L. G.
    Ortiz, Santiago A. J.
    Schneeweiss, S.
    Najafzadeh, M.
    VALUE IN HEALTH, 2019, 22 : S161 - S161
  • [30] Empagliflozin selected cardiovascular and safety outcomes in routine care: First results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Patorno, E.
    Pawar, A.
    Franklin, J. M.
    Najafzadeh, M.
    Deruaz-Luyet, A.
    Brodovicz, K. G.
    Sambevski, S.
    Bessette, L. G.
    Kulldorff, M.
    Schneeweiss, S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104
12345